Concepedia

Publication | Open Access

Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase

127

Citations

21

References

2018

Year

Abstract

Novartis Pharmaceuticals Corporation.

References

YearCitations

Page 1